Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection

Clinical Science

Volumn 97, Issue 6, 1999, Pages 707-718

  Price, David A ^a   O'Callaghan, Chris A ^a   Whelan, Joseph A ^a   Easterbrook, Philippa J ^a   Phillips, Rodney E ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Anti viral agents; Antigenic variation; Cytotoxic T lymphocytes; HIV 1; Primary infection; Seroconversion

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD45 ANTIGEN; CD8 ANTIGEN; EPITOPE;

ACUTE PHASE RESPONSE; AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ANTIGENIC VARIATION; ANTIVIRAL ACTIVITY; ARTICLE; CELL POPULATION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE STRUCTURE; GENETIC SELECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VACCINATION; VIREMIA; VIRUS GENE; VIRUS REPLICATION;

EID: 0033385110     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0970707     Document Type: Article

References (76)

1. 1 United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) (1998) Report on the Global HIV/AIDS Epidemic. UNAIDS Geneva
2. 2 Quinn, T. C. (1996) Global burden of the HIV pandemic. Lancet 348, 99-106
3. 3 Walker, B. D., Chakrabarti, S., Moss, B. et al. (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (London) 328, 345-348
4. 4 Plata, F., Autran, B., Pedroza-Martins, L. et al. (1987) AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (London) 328, 348-351
5. 5 Zinkernagel, R. M. and Hengartner, H. (1994) T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today 15, 262-268
6. 6 Klein, M. R., van der Burg, S. H., Pontesilli, O. and Micdema, F. (1998) Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox? Immunol. Today 19, 317-324
7. 7 Koup, R. A., Safrit, J. T., Cao, Y. et al. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655
8. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103-6110
9. 9 Gotch, F. M., Nixon, D. F., Alp, N., McMichael, A. J. and Borysiewicz, L. K. (1990) High frequency of memory and effector Gag-specific cytotoxic T lymphocytes in HIV-seropositive individuals. Int. Immunol. 2, 707-712
10. 10 Moss, P. A. H., Rowland-Jones, S. L., Frodsham, P. M. et al. (1995) Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. U.S.A. 92, 5773-5777
11. 11 Altman, J. D., Moss, P. A. H., Goulder, P. J. R. et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96
12. 12 Carmichael, A., Jin, X., Sissons, P. and Borysiewicz, L. (1993) Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177, 249-256
13. 13 Klein, M. R., van Baalen, C. A., Holwerda, A. M. et al. (1995) Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181, 1365-1372
14. 14 Rinaldo, C., Huang, X.-L., Fan, Z. et al. (1995) High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69, 5838-5842
15. 15 Goulder, P. J. R., Phillips, R. E., Colbert, R. A. et al. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. (N.Y.) 3, 212-217
16. 16 Yang, O. O., Kalams, S. A., Rosenzweig, M. et al. (1996) Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70, 5799-5806
17. 17 Doherty, P. C., Allan, W., Eichelberger, M. and Carding, S. R. (1992) Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10, 123-151
18. 18 Pantaleo, G., Graziosi, C., Demarest, J. F. et al. (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362, 355-358
19. 19 Embretson, J., Zupancic, M., Ribas, J. L. et al. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362, 359-362
20. 20 Wei, X., Ghosh, S. K., Taylor, M. E. et al. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373, 117-122
21. 21 Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. and Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373, 123-126
22. 22 Mathieson, B. J. (1995) CTL to HIV-1: surrogates or sirens? Nat. Med. (N.Y.) 1, 304-305
23. 23 Feinberg, M. B. and McLean, A. R. (1997) AIDS: decline and fall of immune surveillance? Curr. Biol. 7, 136-140
24. 24 Holland, J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S. and VandePol, S. (1982) Rapid evolution of RNA genomes. Science 215, 1577-1585
25. 25 Roberts, J. D., Bebenek, K. and Kunkel, T. A. (1988) The accuracy of reverse transcriptase from HIV-1. Science 242, 1171-1173
26. 26 Hu, W.-S. and Temin, H. M. (1990) Retroviral recombination and reverse transcription. Science 250, 1227-1233
27. 27 Wolinsky, S. M., Korber, B. T. M., Neumann, A. U. et al. (1996) Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272, 537-542
28. 28 Pamer, E. and Cresswell, P. (1998) Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16, 323-358
29. 29 Goulder, P. J. R., Reid, S. W., Price, D. A. et al. (1997) Combined structural and immunological refinement of HIV-1 HLA B8-restricted cytotoxic T lymphocyte epitopes. Eur. J. Immunol. 27, 1515-1521
30. 30 Rammensee, H.-G., Friede, T. and Stevanovic, S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228
31. 31 Price, D. A., Goulder, P. J. R., Klenerman, P. et al. (1997) Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. U.S.A. 94, 1890-1895
32. 32 Nei, M. and Gojobori, T. (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3, 418-426
33. 33 Endo, T., Ikeo, K. and Gojobori, T. (1996) Large-scale search for genes on which positive selection may operate. Mol. Biol. Evol. 13, 685-690
34. 34 Wu, T. T. and Kabat, E. A. (1970) An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132, 211-250
35. 35 Phillips, R. E., Rowland-Jones, S., Nixon, D. F. et al. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (London) 354, 453-459
36. 36 Couillin, I., Culmann-Penciolelli, B., Gomard, E. et al. (1994) Impaired cytotoxic T lymphocyte recognition due to genetic variation in the main immunogenic region of the human immunodeficiency virus 1 Nef protein. J. Exp. Med. 180, 1129-1134
37. 37 Goodenow, M., Huet, T., Saurin, W., Kwok, S., Sninsky, J. and Wain-Hobson, S. (1989) HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. AIDS 2, 344-352
38. 38 Clark, S. J., Saag, M. S., Decker, W. D. et al. (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324, 954-960
39. 39 Daar, E. S., Moudgil, T., Meyer, R. D. and Ho, D. D. (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324, 961-964
40. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature (London) 370, 463-467
41. + T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188, 785-790
42. 42 Pircher, H., Moskophidis, D., Rohrer, U., Buerki, K., Hengartner, H. and Zinkernagel, R. M. (1990) Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (London) 346, 629-633
43. 43 Goulder, P., Price, D., Nowak, M., Rowland-Jones, S., Phillips, R. and McMichael, A. (1997) Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol. Rev. 159, 17-29
44. 44 Borrow, P., Lewicki, H., Wei, X. et al. (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. (N.Y.) 3, 205-211
45. 45 McMichael, A. J. and Phillips, R. E. (1997) Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15, 271-296
46. 46 Coffin, J. M. (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489
47. 47 Ho, D. D. (1995) Time to hit HIV, early and hard. N. Engl. J. Med. 333, 450-451
48. 48 McMichael, A. J. and O'Callaghan, C. A. (1998) A new look at T cells. J. Exp. Med. 187, 1367-1371
49. 49 Ogg, G. S. and McMichael, A. J. (1998) HLA-peptide tetrameric complexes. Curr. Opin. Immunol. 10, 393-396
50. 50 Howard, M. C., Spack, E. G., Choudhury, K., Greten, T. F. and Schneck, J. P. (1999) MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes. Immunol. Today 20, 161-165
51. 51 Pakker, N. G., Notermans, D. W., de Boer, R. J. et al. (1998) Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. (N.Y.) 2, 208-214
52. 52 Gallimore, A., Glithero, A., Godkin, A. et al. (1998) Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric MHC class I-peptide complexes. J. Exp. Med. 187, 1383-1393
53. 1 T cell responses associated with control of viremia. Science 278, 1447-1450
54. + T cells. J. Exp. Med. 186, 1407-1418
55. 55 Hintzen, R. Q., de Jong, R., Lens, S. M. A., Brouwer, M., Baars, P. and van Lier, R. A. W. (1993) Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 151, 2426-2435
56. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 155, 5046-5056
57. 57 Zajac, A. J., Blattman, J. N., Murali-Krishna, K. et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213
58. 58 Wong, J. K., Hezarch, M., Guenthard, H. F. et al. (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-1295
59. 59 Finzi, D., Hermankova, M., Pierson, T. et al. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300
60. 60 Zhu, T., Mo, H., Wang, N, et al. (1993) Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261, 1179-1181
61. 61 McCune, J. M. (1995) Viral latency in HIV disease. Cell 82, 183-188
62. 62 Chun, T.-W., Carruth, L., Finzi, D. et al, (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (London) 387, 183-188
63. + T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 95, 8869-8873
64. 64 Ogg, G. S., Jin, X., Bonhoeffer, S. et al. (1999) Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73, 797-800
65. 65 Dunbar, P. R., Ogg, G. S., Chen, J. et al. (1998) Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8, 413-416
66. 66 Juriaans, S., van Gemen, B. and Weverling, G. J. (1994) The natural history of HIV-1 infection, virus load and virus phenotype independent determinants of clinical course? Virology 204, 223-233
67. 67 Henrard, D. R., Phillips, J. F., Muenz, L. R. et al. (1995) Natural history of HIV-1 cell-free viraemia. J. Am. Med. Assoc. 274, 554-558
68. 68 Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L. and McElrath, M. J. (1997) Cytotoxic T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337, 1267-1274
69. 69 Pantaleo, G., Demarest, J, F., Schacker, T. et al. (1997) The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. U.S.A. 94, 254-258
70. 70 Mellors, J. W., Kingsley, L. A., Rinaldo, Jr., C. R. et al. (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122, 573-579
71. 71 Mellors, J. W., Rinaldo, Jr., C. R., Gupta, P., White, R. M., Todd, J. A. and Kingsley, L. A. (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170
72. 72 Koenig, S., Conley, A. J., Brewah, Y. A. et al. (1995) Transfer of HIV-1-specific cylotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. (N.Y.) 1, 330-336
73. 73 Ogg, G. S., Jin, X., Bonhoeffer, S. et al. (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106
74. 74 Klenerman, P., Phillips, R. E., Rinaldo, C. R. et al. (1996) Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 93, 15323-15328
75. 75 Nowak, M. A. and Bangham, C. R. M. (1996) Population dynamics of immune responses to persistent viruses. Science 272, 74-79
76. + lymphocytes. Science 283, 857-860